[{"address1": "822 A1A North", "address2": "Suite 306", "city": "Ponte Vedra", "state": "FL", "zip": "32082", "country": "United States", "phone": "904 300 0701", "website": "https://www.cadrenal.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Quang X. Pham", "age": 59, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1130081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew K. Szot CPA, CPA", "age": 50, "title": "Co-Founder & CFO", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 712776, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Cole", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 615361, "exercisedValue": 0, "unexercisedValue": 16298}, {"maxAge": 1, "name": "Dr. James J. Ferguson FACC, M.D.", "age": 70, "title": "Chief Medical Officer", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.65, "open": 11.5, "dayLow": 11.0001, "dayHigh": 11.7999, "regularMarketPreviousClose": 11.65, "regularMarketOpen": 11.5, "regularMarketDayLow": 11.0001, "regularMarketDayHigh": 11.7999, "payoutRatio": 0.0, "forwardPE": -2.459746, "volume": 16621, "regularMarketVolume": 16621, "averageVolume": 25325, "averageVolume10days": 16580, "averageDailyVolume10Day": 16580, "bid": 13.0, "ask": 13.99, "bidSize": 1, "askSize": 2, "marketCap": 24298070, "fiftyTwoWeekLow": 8.74, "fiftyTwoWeekHigh": 22.901, "allTimeHigh": 101.25, "allTimeLow": 5.4, "fiftyDayAverage": 13.2996, "twoHundredDayAverage": 14.61974, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20240478, "profitMargins": 0.0, "floatShares": 1537018, "sharesOutstanding": 2075845, "sharesShort": 28386, "sharesShortPriorMonth": 9933, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0139, "heldPercentInsiders": 0.25594, "heldPercentInstitutions": 0.085260004, "shortRatio": 1.1, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 2092857, "bookValue": 1.328, "priceToBook": 8.74247, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -14385641, "trailingEps": -8.72, "forwardEps": -4.72, "lastSplitFactor": "1:15", "lastSplitDate": 1724112000, "enterpriseToEbitda": -1.38, "52WeekChange": -0.28615195, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 11.61, "targetHighPrice": 45.0, "targetLowPrice": 30.0, "targetMeanPrice": 35.66667, "targetMedianPrice": 32.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 3860082, "totalCashPerShare": 1.86, "ebitda": -14667773, "totalDebt": 0, "quickRatio": 2.863, "currentRatio": 3.016, "returnOnAssets": -2.09231, "returnOnEquity": -4.6803102, "freeCashflow": -7580527, "operatingCashflow": -11822413, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CVKD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763166133, "regularMarketTime": 1763154002, "exchange": "NCM", "messageBoardId": "finmb_1793167154", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.343347, "shortName": "Cadrenal Therapeutics, Inc.", "marketState": "CLOSED", "regularMarketPrice": 11.61, "postMarketChangePercent": 1.9810551, "postMarketPrice": 11.84, "postMarketChange": 0.2300005, "regularMarketChange": -0.04, "regularMarketDayRange": "11.0001 - 11.7999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 25325, "fiftyTwoWeekLowChange": 2.87, "fiftyTwoWeekLowChangePercent": 0.32837528, "fiftyTwoWeekRange": "8.74 - 22.901", "fiftyTwoWeekHighChange": -11.290999, "fiftyTwoWeekHighChangePercent": -0.49303523, "fiftyTwoWeekChangePercent": -28.615194, "earningsTimestampStart": 1754564340, "earningsTimestampEnd": 1755777600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -8.72, "epsForward": -4.72, "epsCurrentYear": -7.19, "priceEpsCurrentYear": -1.6147426, "fiftyDayAverageChange": -1.6896, "fiftyDayAverageChangePercent": -0.12704141, "twoHundredDayAverageChange": -3.0097399, "twoHundredDayAverageChangePercent": -0.20586823, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-01-20", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1674225000000, "longName": "Cadrenal Therapeutics, Inc.", "displayName": "Cadrenal Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]